CCCC
C4 Therapeutics Inc
3.10$
-6.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -87.7% | 260.1% | -202.6% | -189.9% | -340.7% | -514.7% | -183.1% | -274.6% | |
| 6.6% | 7.5% | 4.9% | 3.3% | 5.4% | 9.1% | 5.1% | 5.4% | |
| 3.0% | 7.7% | 10.3% | 47.0% | 96.5% | 131.2% | 83.4% | 53.1% | |
| 3.7% | 9.3% | 30.8% | 47.0% | 96.5% | – | – | – | |
| -28.7% | 397.5% | -39.7% | -65.7% | -54.0% | -33.4% | 21.5% | -81.5% | |
| 13.9% | 6.3% | 2.0% | 2.8% | 17.7% | 8.2% | 0.5% | 1.7% | |
| 190.7% | -7.6% | -573.9% | -413.5% | 187.9% | 762.9% | -144.1% | -23.9% | |
| – | – | 36.1% | – | – | – | – | – | |
| -0.3% | -0.1% | -0.6% | 4.5% | 2.5% | -0.5% | -0.5% | -0.5% | |
| 64.4% | 58.3% | 37.6% | 0.0% | 0.0% | -60.2% | 0.0% | – | |
| 10.1% | 1.1% | 1,051.2% | 374.4% | 3.7% | 219.2% | 127.4% | 351.6% | |
| 113.1% | 253.7% | 274.7% | -229.1% | -149.1% | 467.3% | -199.8% | 53.1% | |
| -101.6% | 253.8% | -204.5% | -192.7% | -358.4% | -523.0% | -183.6% | -276.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.